Standard Biotools (LAB) Enterprise Value (2011 - 2026)

Standard Biotools (LAB) has reported Enterprise Value for 16 consecutive years, with -$155.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value fell 171.07% year-over-year to -$155.2 million in Q2 2026; TTM through Jun 2026 was -$155.2 million, a 171.07% decrease from a year earlier, with the FY2025 full-year figure at $307.0 million, down 16.06% from the prior year.
• Enterprise Value was -$155.2 million for Q2 2026 at Standard Biotools, down from -$96.5 million in the prior quarter.
• Over five years, Enterprise Value peaked at $365.7 million in Q4 2024 and troughed at -$155.2 million in Q2 2026.
• A 5-year average of $121.9 million and a median of $124.8 million in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value jumped 17110.63% in 2024 and tumbled 171.07% in 2026, its largest moves.
• Over 5 years, Enterprise Value stood at -$73.8 million in 2022, then soared by 183.49% to $61.6 million in 2023, then soared by 493.47% to $365.7 million in 2024, then fell by 16.06% to $307.0 million in 2025, then sank by 150.55% to -$155.2 million in 2026.
• The last three Enterprise Value figures came in at -$155.2 million (Q2 2026), -$96.5 million (Q1 2026), and $307.0 million (Q4 2025), per Business Quant data.